Therapeutic Areas

Advancing Preclinical Breakthroughs in Diverse Central Nervous System (CNS) Therapeutic Areas
At PsychoGenics, we are dedicated to pushing the boundaries of scientific research and drug development in various therapeutic areas within the overall preclinical central nervous system (CNS) research field.
Epilepsy & Seizure Disorders

At PsychoGenics, we provide expert preclinical epilepsy and seizure disorder studies and services to help you discover your breakthrough therapy. Our capabilities cover EEG and behavioral identification of seizures. We excel in developing, executing, and analyzing complex rodent EEG studies. Our proficiency in interpreting intricate EEG data provides you with a distinctive edge, delivering the evidence required to propel your research forward. Our translational animal disease models have been well characterized to allow trusted efficacy investigations, ensuring understanding of your drug’s potential.

Learn more
Mental Illness

PsychoGenics stands at the forefront of preclinical mental illness research. Our state-of-the-art facilities, coupled with predictive rodent models and a large catalog of behavioral assays is unmatched in the industry. Our in-house-developed SmartCube® platform exemplifies our innovation and commitment to industrializing phenotypic drug discovery for mental illness therapies and providing data-rich insights. Partnering with us means tapping into an unparalleled blend of technological sophistication, bespoke solutions, and a stellar track record in mental illness drug discovery.

Learn more
Neurodegenerative Disorders
PsychoGenics has established itself as a reputable partner in preclinical research for neurodegenerative disorders. Our depth of expertise in preclinical CNS studies combined with a diverse portfolio of rodent disease models positions us to champion the development of groundbreaking treatments.
Learn more
Neurodevelopmental Disorders
Backed by extensive experience, our scientists possess the deep understanding needed to design and execute early-stage preclinical neurodevelopmental disorders studies. We employ rigorous and standardized assessments to evaluate your compound in animal models of neurodevelopmental disorders, ensuring dependable and actionable data that propel your research and drug development forward.
Learn more
Neuromuscular Disorders
PsychoGenics is at the forefront of preclinical neuromuscular disorders research, combining long-standing expertise with advanced scientific tools. Our dedication to understanding the challenges of these disorders is evident in our approach, where leading methodologies merge with a collaborative spirit. This synergy is geared toward bringing your next groundbreaking achievement to light.
Learn more
Pain Models
PsychoGenics is a leading authority in preclinical research for pain disorders, dedicated to advancing the development of effective therapies to alleviate pain and improve patient outcomes. PsychoGenics is equipped with state-of-the-art facilities and resources to support pain research projects of any scale.
Learn more
Rare CNS Disorders
PsychoGenics offers specialized preclinical research services tailored to rare CNS disorders to drive your program forward. Leveraging our translational research expertise, broad range of tests and rodent models, and customized, collaborative approach, we offer superior preclinical research support for your program to address the unique challenges posed by these conditions.
Learn more
Injury and Trauma
At PsychoGenics, we are dedicated to advancing preclinical traumatic brain injury (TBI) and spinal cord injury (SCI) research. We utilize rodent injury models and testing platforms to aid you in the development of effective therapies.
Learn more